VISIPAQUE 320 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Visipaque 320, and what generic alternatives are available?
Visipaque 320 is a drug marketed by Ge Healthcare and is included in two NDAs.
The generic ingredient in VISIPAQUE 320 is iodixanol. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iodixanol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Visipaque 320
A generic version of VISIPAQUE 320 was approved as iodixanol by HENGRUI PHARMA on May 19th, 2022.
Summary for VISIPAQUE 320
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 31 |
Patent Applications: | 4,049 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VISIPAQUE 320 at DailyMed |
Recent Clinical Trials for VISIPAQUE 320
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Institute of Liver and Biliary Sciences, India | N/A |
Guerbet | Phase 1 |
University of Washington | Phase 1 |
Pharmacology for VISIPAQUE 320
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for VISIPAQUE 320
US Patents and Regulatory Information for VISIPAQUE 320
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020808-002 | Aug 29, 1997 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VISIPAQUE 320
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020808-002 | Aug 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020808-002 | Aug 29, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VISIPAQUE 320
See the table below for patents covering VISIPAQUE 320 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Sweden | 7905830 | ⤷ Try a Trial | |
Japan | H05504953 | ⤷ Try a Trial | |
Portugal | 96978 | PROCESSO PARA A PREPARACAO DE MEIOS DE CONTRASTE AOS RAIOS X NAO IONICOS | ⤷ Try a Trial |
Norway | 304352 | ⤷ Try a Trial | |
Finland | 792101 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for VISIPAQUE 320
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0108638 | 97C0101 | Belgium | ⤷ Try a Trial | PRODUCT NAME: IODIXANOL; NAT. REGISTRATION NO/DATE: 914 IS 204 F 12 19970325; FIRST REGISTRATION: SE 11758 19930205 |
0108638 | SPC/GB93/150 | United Kingdom | ⤷ Try a Trial | SPC/GB93/150, 20031107, EXPIRES: 20080330 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |